In vitro assays offer a cost-effective, efficient, and highly reliable way to screen candidate compounds in the early stages of drug development. Whether identifying promising, novel agents or aiming to enhance existing treatments, in vitro assays can be applied to a wide range of systems, from simple mono-cultures of immortalized cell lines to complex cultures of patient-derived tissue samples or iPSC-derived cells.

High-stakes decision making is at the heart of drug discovery and development. Uncertainty about targets, mechanisms of action, and whether to advance or abandon candidate compounds is the norm.

Because they provide only limited data, conventional low-plex in vitro assays don’t bring enough clarity to these complex questions.

With our expertise in the development and use of high-content imaging-based phenotypic assays, we deliver the biological insights and high-quality data you need to inform and de-risk R&D decisions.

Our team helps you understand complex biology, with high-content imaging as our primary technique. We excel in in vitro assay development, using cutting-edge equipment and data analysis to support your research needs.